Why the study?
Do diabetic patients with microalbuminuria have higher plasma levels of sVCAM-1 compared to those without microalbuminuria?
Do diabetic patients with microalbuminuria have higher plasma levels of sVCAM-1 compared to those without microalbuminuria?
Answers are grounded in this paper and cite their sources.
Plasma sVCAM-1 is elevated in diabetic patients with microalbuminuria, suggesting it may serve as a biomarker for early vascular dysfunction and diabetic vasculopathy.
Advanced glycation endproducts (AGEs), which accumulate in diabetic vasculature, result in enhanced expression of endothelial cell-associated vascular cell adhesion molecule-1 (VCAM-1) as well release of a soluble form of VCAM-1 (sVCAM-1) into culture supernatants. We hypothesized that sVCAM-1 in diabetic plasma might reflect early vascular perturbation in diabetic vasculopathy. Diabetic patients with microalbuminuria, a group with a high incidence of vascular complications, had increased plasma levels of sVCAM-1, approximately 1.5-fold greater than diabetic patients without microalbuminuria; P < 0.05. sVCAM-1 may be an indicator of ongoing cellular dysfunction in diabetes, as well as a dynamic surrogate marker for the effectiveness of therapeutic interventions.
No takes yet. Share an insight, caveat, or question.
Schmidt et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: